Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer

• Главные авторы: Wesam Abdel-Razaq (Автор), Mohammed Alzahrani (Автор), Majed Al Yami (Автор), Faisal Almugibl (Автор), Mohammed Almotham (Автор), Razan Alregaibah (Автор)
• Формат: ‌
• Опубликовано: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Context: Although trastuzumab is a highly effective and selective targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer, the drug-induced cardiotoxicity may confine its usefulness in patients. Aim: To explore risk factors associated with the development of cardi...